Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 28,298 | 23,038 | 16,960 | 29,937 | 28,626 |
| Operating Income | -28,298 | -23,038 | -16,960 | -29,937 | -28,626 |
| Interest Expense | 3,259 | 3,255 | 3,564 | 3,506 | 2,017 |
| Other Income | 193 | -1,072 | 448 | 192 | -104 |
| Pre-tax Income | -31,364 | -27,365 | -20,076 | -33,251 | -30,747 |
| Income Tax | -580 | 85 | 70 | 30,193 | -4,323 |
| Net Income Continuous | -30,784 | -27,450 | -20,146 | -63,444 | -26,424 |
| Net Income | $-30,784 | $-27,450 | $-20,146 | $-63,444 | $-26,424 |
| EPS Basic Total Ops | -0.48 | -0.44 | -0.33 | -1.07 | -0.45 |
| EPS Basic Continuous Ops | -0.48 | -0.43 | -0.33 | -1.07 | -0.45 |
| EPS Diluted Total Ops | -0.48 | -0.44 | -0.33 | -1.07 | -0.45 |
| EPS Diluted Continuous Ops | -0.48 | -0.43 | -0.33 | -1.07 | -0.45 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.44 | -0.33 | N/A | N/A |
| EBITDA(a) | $-27,710 | $-22,452 | $-16,559 | $-29,690 | $-28,367 |